Literature DB >> 18502133

Diarylmethyloxime and hydrazone derivatives with 5-indolyl moieties as potent inhibitors of tubulin polymerization.

Concepción Alvarez1, Raquel Alvarez, Purificación Corchete, José Luis López, Concepción Pérez-Melero, Rafael Peláez, Manuel Medarde.   

Abstract

We describe the synthesis and biological evaluation of a series of diarylmethyloxime and diarylmethylhydrazone analogues that contain an indole ring and different modifications on the nitrogen of the bridge. Several compounds showed potent tubulin polymerization inhibitory action as well as cytotoxic activity against cancer cell lines. The N-methyl-5-indolyl substituted analogues are more potent than ethyl substituted ones. The most potent inhibitors of tubulin polymerization are the diarylketones and the diaryloximes. The cytotoxicity against several cancer cell lines is lower for the oximes than for the ketones. Other substitutions on the imine nitrogen greatly reduce the tubulin inhibitory and/or cytotoxic potencies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502133     DOI: 10.1016/j.bmc.2008.04.054

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  (E)-N'-(2-Hydr-oxy-4-methoxy-benzyl-idene)isonicotinohydrazide monohydrate.

Authors:  San-Jun Peng; Hai-Yun Hou
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-09-24

2.  (E)-N'-(4-Hydroxy-benzyl-idene)-2-methoxy-benzohydrazide.

Authors:  Xue-Hui Zhan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-09-24

3.  N'-(5-Bromo-2-hydr-oxy-3-methoxy-benzyl-idene)isonicotinohydrazide.

Authors:  San-Jun Peng; Hai-Yun Hou
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-09-24

4.  4-Dimethyl-amino-N'-(3-pyridyl-methyl-idene)benzohydrazide.

Authors:  Yan-Wei Ding; Li-Li Ni
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-09-25

5.  Structurally simplified biphenyl combretastatin A4 derivatives retain in vitro anti-cancer activity dependent on mitotic arrest.

Authors:  Daniel Tarade; Dennis Ma; Christopher Pignanelli; Fadi Mansour; Daniel Simard; Sean van den Berg; James Gauld; James McNulty; Siyaram Pandey
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

6.  The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions on Combretastatin and Isocombretastatin Tubulin Inhibitors.

Authors:  Myriam González; Younes Ellahioui; Raquel Álvarez; Laura Gallego-Yerga; Esther Caballero; Alba Vicente-Blázquez; Laura Ramudo; Miguel Marín; Cristina Sanz; Manuel Medarde; Rafael Pelaéz
Journal:  Molecules       Date:  2019-11-26       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.